Multi-target approach for Alzheimer’s disease treatment: computational biomolecular modeling of cholinesterase enzymes with a novel 4-<i>N</i>-phenylaminoquinoline derivative reveal promising potentials-Reference-Cited by-同舟云学术

Multi-target approach for Alzheimer’s disease treatment: computational biomolecular modeling of cholinesterase enzymes with a novel 4-N-phenylaminoquinoline derivative reveal promising potentials

Published:2020-10-08 Issue:11 Volume:39 Page:3825-3841
ISSN:0739-1102
Container-title:Journal of Biomolecular Structure and Dynamics
language:en
Short-container-title:Journal of Biomolecular Structure and Dynamics

Author:

Adeowo Fatima Y.¹,Ejalonibu Murtala A.¹,Elrashedy Ahmed A.²,Lawal Monsurat M.¹,Kumalo Hezekiel M.¹

Affiliation:

1. Drug Research and Innovation Unit, Discipline of Medical Biochemistry, School of Laboratory Medicine and Medical Science, University of KwaZulu-Natal, Durban, South Africa

2. Molecular Bio-computational and Drug Design Research Group, School of Health Sciences, University of KwaZulu-Natal, Durban, South Africa

Funder

the College of Health Sciences, University of KwaZulu Natal, Durban, South Africa, and South African National Research Foundation

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/07391102.2020.1826129

Reference120 articles.

1. The interaction of NOTA as a bifunctional chelator with competitive alkali metal ions: a DFT study

2. Density Functional Theory Study on the Complexation of NOTA as a Bifunctional Chelator with Radiometal Ions

3. A molecular approach in drug development for Alzheimer’s disease

4. A review on cholinesterase inhibitors for Alzheimer’s disease

5. Neuroprotective and Cholinergic Properties of Multifunctional Glutamic Acid Derivatives for the Treatment of Alzheimer’s Disease

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring Chalcone Derivatives as a Multifunctional Therapeutic Agent: Investigating Antioxidant Potential, Acetylcholinesterase Inhibition and Computational Insights;Drugs and Drug Candidates;2025-04-14

2. Enzymatic Targets for Drug Discovery Against Alzheimer's Disease;Enzymatic Targets for Drug Discovery Against Alzheimer's Disease;2023-12-28

3. Microorganism-Derived Molecules as Enzyme Inhibitors to Target Alzheimer’s Diseases Pathways;Pharmaceuticals;2023-04-12

4. Pharmacophore mapping of the crucial mediators of acetylcholinesterase and butyrylcholinesterase dual inhibition in Alzheimer's disease;Molecular Diversity;2022-01-24

5. Jatamansinol from Nardostachys jatamansi: a multi-targeted neuroprotective agent for Alzheimer’s disease;Journal of Biomolecular Structure and Dynamics;2021-12-02